Skip to main content

Medications for Acute Lymphoblastic Leukemia

Cancer of a specific type of white blood cell called lymphocytes.

Drugs used to treat Acute Lymphoblastic Leukemia

The following list of medications are in some way related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
methotrexate Rate Add review
Rx X N X
Generic name:
methotrexate systemic
Brand names:
Trexall, Xatmep, Jylamvo
Drug class:
antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
mercaptopurine Rate Add review
Rx D N
Generic name:
mercaptopurine systemic
Brand names:
Purixan, Purinethol
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Gleevec 10 1 review for Gleevec to treat Acute Lymphoblastic Leukemia
Rx D N
Generic name:
imatinib systemic
Drug class:
BCR-ABL tyrosine kinase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Blincyto 10 1 review for Blincyto to treat Acute Lymphoblastic Leukemia
Rx C N
Generic name:
blinatumomab systemic
Drug class:
CD19 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
blinatumomab 10 2 reviews for blinatumomab to treat Acute Lymphoblastic Leukemia
Rx C N
Generic name:
blinatumomab systemic
Brand name:
Blincyto
Drug class:
CD19 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Kymriah Rate Add review
Rx N
Generic name:
tisagenlecleucel systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Sprycel 10 1 review for Sprycel to treat Acute Lymphoblastic Leukemia
Rx D N
Generic name:
dasatinib systemic
Drug class:
BCR-ABL tyrosine kinase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
dasatinib 10 1 review for dasatinib to treat Acute Lymphoblastic Leukemia
Rx D N
Generic name:
dasatinib systemic
Brand names:
Sprycel, Phyrago
Drug class:
BCR-ABL tyrosine kinase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
pegaspargase 1.0 2 reviews for pegaspargase to treat Acute Lymphoblastic Leukemia
Rx C N X
Generic name:
pegaspargase systemic
Brand name:
Oncaspar
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
imatinib 10 1 review for imatinib to treat Acute Lymphoblastic Leukemia
Rx D N
Generic name:
imatinib systemic
Brand name:
Gleevec
Drug class:
BCR-ABL tyrosine kinase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Trexall Rate Add review
Rx X N X
Generic name:
methotrexate systemic
Drug class:
antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
doxorubicin Rate Add review
Rx D N
Generic name:
doxorubicin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Iclusig 1.0 1 review for Iclusig to treat Acute Lymphoblastic Leukemia
Rx D N
Generic name:
ponatinib systemic
Drug class:
multikinase inhibitors, BCR-ABL tyrosine kinase inhibitors, VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Purixan Rate Add review
Rx D N
Generic name:
mercaptopurine systemic
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
ponatinib 1.0 1 review for ponatinib to treat Acute Lymphoblastic Leukemia
Rx D N
Generic name:
ponatinib systemic
Brand name:
Iclusig
Drug class:
multikinase inhibitors, BCR-ABL tyrosine kinase inhibitors, VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Xatmep Rate Add review
Rx X N X
Generic name:
methotrexate systemic
Drug class:
antimetabolites, antirheumatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
asparaginase erwinia chrysanthemi Rate Add review
Rx C N X
Generic name:
asparaginase erwinia chrysanthemi systemic
Brand names:
Erwinaze, Rylaze
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Purinethol Rate Add review
Rx D N
Generic name:
mercaptopurine systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
vincristine liposome Rate Add review
Rx D N
Generic name:
vincristine liposome systemic
Brand name:
Marqibo
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
Oncaspar Rate Add review
Rx C N X
Generic name:
pegaspargase systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Marqibo Rate Add review
Rx D N
Generic name:
vincristine liposome systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
Besponsa Rate Add review
Rx N
Generic name:
inotuzumab ozogamicin systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Erwinaze Rate Add review
Rx C N X
Generic name:
asparaginase erwinia chrysanthemi systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Jylamvo Rate Add review
Rx X N X
Generic name:
methotrexate systemic
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Arranon Rate Add review
Rx D N
Generic name:
nelarabine systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Learn more about Acute Lymphoblastic Leukemia

Care guides

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.